These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
361 related items for PubMed ID: 14519636
1. p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. Perrone F, Tabano S, Colombo F, Dagrada G, Birindelli S, Gronchi A, Colecchia M, Pierotti MA, Pilotti S. Clin Cancer Res; 2003 Sep 15; 9(11):4132-8. PubMed ID: 14519636 [Abstract] [Full Text] [Related]
2. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors. Endo M, Kobayashi C, Setsu N, Takahashi Y, Kohashi K, Yamamoto H, Tamiya S, Matsuda S, Iwamoto Y, Tsuneyoshi M, Oda Y. Clin Cancer Res; 2011 Jun 01; 17(11):3771-82. PubMed ID: 21262917 [Abstract] [Full Text] [Related]
3. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations. Perrone F, Tamborini E, Dagrada GP, Colombo F, Bonadiman L, Albertini V, Lagonigro MS, Gabanti E, Caramuta S, Greco A, Torre GD, Gronchi A, Pierotti MA, Pilotti S. Cancer; 2005 Jul 01; 104(1):159-69. PubMed ID: 15929122 [Abstract] [Full Text] [Related]
4. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma. Furonaka O, Takeshima Y, Awaya H, Ishida H, Kohno N, Inai K. Pathol Int; 2004 Aug 01; 54(8):549-55. PubMed ID: 15260845 [Abstract] [Full Text] [Related]
5. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Edmunds SC, Kelsell DP, Hungerford JL, Cree IA. Invest Ophthalmol Vis Sci; 2002 Sep 01; 43(9):2845-51. PubMed ID: 12202501 [Abstract] [Full Text] [Related]
6. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma. Chinnasri P, Pairojkul C, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tantimavanich S, Limpaiboon T. Hum Pathol; 2009 Jun 01; 40(6):817-26. PubMed ID: 19200577 [Abstract] [Full Text] [Related]
7. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc. Haviernik P, Schmidt M, Hu X, Wolff L. Oncogene; 2003 Mar 20; 22(11):1600-10. PubMed ID: 12642863 [Abstract] [Full Text] [Related]
8. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA. Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779 [Abstract] [Full Text] [Related]
9. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C. Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835 [Abstract] [Full Text] [Related]
10. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS. Arch Otolaryngol Head Neck Surg; 2006 Apr 25; 132(4):409-15. PubMed ID: 16618910 [Abstract] [Full Text] [Related]
11. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas. Nakamura M, Sakaki T, Hashimoto H, Nakase H, Ishida E, Shimada K, Konishi N. Cancer Res; 2001 Sep 01; 61(17):6335-9. PubMed ID: 11522621 [Abstract] [Full Text] [Related]
12. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G. Am J Pathol; 2001 Aug 01; 159(2):661-9. PubMed ID: 11485924 [Abstract] [Full Text] [Related]
13. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus. Gilley J, Fried M. Oncogene; 2001 Nov 01; 20(50):7447-52. PubMed ID: 11704876 [Abstract] [Full Text] [Related]
14. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status. Chaussade L, Eymin B, Brambilla E, Gazzeri S. Oncogene; 2001 Oct 04; 20(45):6587-96. PubMed ID: 11641784 [Abstract] [Full Text] [Related]
15. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma. Hutter G, Scheubner M, Zimmermann Y, Kalla J, Katzenberger T, Hübler K, Roth S, Hiddemann W, Ott G, Dreyling M. Genes Chromosomes Cancer; 2006 Feb 04; 45(2):203-10. PubMed ID: 16258956 [Abstract] [Full Text] [Related]
16. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma. Peng CY, Chen TC, Hung SP, Chen MF, Yeh CT, Tsai SL, Chu CM, Liaw YF. Anticancer Res; 2002 Feb 04; 22(2B):1265-71. PubMed ID: 12168936 [Abstract] [Full Text] [Related]
17. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors. Arcellana-Panlilio MY, Egeler RM, Ujack E, Magliocco A, Stuart GC, Robbins SM, Coppes MJ. Genes Chromosomes Cancer; 2002 Oct 04; 35(2):176-81. PubMed ID: 12203782 [Abstract] [Full Text] [Related]
18. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck. Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A. Virchows Arch; 2002 Aug 04; 441(2):133-42. PubMed ID: 12189502 [Abstract] [Full Text] [Related]
19. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma. Kanellou P, Zaravinos A, Zioga M, Spandidos DA. Br J Dermatol; 2009 Jun 04; 160(6):1215-21. PubMed ID: 19298278 [Abstract] [Full Text] [Related]
20. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1. Fang Y, Elahi A, Denley RC, Rao PH, Brennan MF, Jhanwar SC. Anticancer Res; 2009 Apr 04; 29(4):1255-62. PubMed ID: 19414372 [Abstract] [Full Text] [Related] Page: [Next] [New Search]